USE OF COMBINED TREATMENT OF PD-1 ANTIBODY AND APATINIB FOR TREATING TRIPLE NEGATIVE BREAST CANCER

摘要

The present invention relates to a use of a combined treatment of a PD-1 antibody and Apatinib for treating Triple Negative Breast Cancer. In particular, the present invention relates to a use of an anti-PD-1 antibody in combination with Apatinib in the preparation of a drug for Triple Negative Breast Cancer.